175 related articles for article (PubMed ID: 27928086)
1. Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa.
Giles-Vernick T; Hejoaka F; Sanou A; Shimakawa Y; Bamba I; Traoré A
Am J Trop Med Hyg; 2016 Dec; 95(6):1368-1375. PubMed ID: 27928086
[TBL] [Abstract][Full Text] [Related]
2. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa.
Coffie PA; Tchounga BK; Bado G; Kabran M; Minta DK; Wandeler G; Gottlieb GS; Dabis F; Eholie SP; Ekouevi DK
BMC Infect Dis; 2017 Jul; 17(1):466. PubMed ID: 28676076
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.
Candotti D; Diarra B; Bisseye C; Tao I; Pham Quang K; Sanou M; Laperche S; Sanogo R; Allain JP; Simpore J
J Med Virol; 2016 Dec; 88(12):2145-2156. PubMed ID: 27253483
[TBL] [Abstract][Full Text] [Related]
5. Screening for Hepatitis B in partners and children of women positive for surface antigen, Burkina Faso.
Guingané AN; Kaboré R; Shimakawa Y; Somé EN; Kania D; Pisoni A; Nagot N; King R; Sombié R; Meda N; Van de Perre P; Tuaillon E
Bull World Health Organ; 2022 Apr; 100(4):256-267. PubMed ID: 35386558
[TBL] [Abstract][Full Text] [Related]
6. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
[TBL] [Abstract][Full Text] [Related]
7. Identifying gaps across the cascade of care for the prevention of HBV mother-to-child transmission in Burkina Faso: Findings from the real world.
Guingané AN; Bougouma A; Sombié R; King R; Nagot N; Meda N; Van de Perre P; Tuaillon E
Liver Int; 2020 Oct; 40(10):2367-2376. PubMed ID: 32633864
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies.
Lingani M; Akita T; Ouoba S; Sanou AM; Sugiyama A; Tarnagda Z; Ohisa M; Tinto H; Mishiro S; Tanaka J
BMC Public Health; 2018 Apr; 18(1):551. PubMed ID: 29699534
[TBL] [Abstract][Full Text] [Related]
9. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.
Shimakawa Y; Njie R; Ndow G; Vray M; Mbaye PS; Bonnard P; Sombié R; Nana J; Leroy V; Bottero J; Ingiliz P; Post G; Sanneh B; Baldeh I; Suso P; Ceesay A; Jeng A; Njai HF; Nayagam S; D'Alessandro U; Chemin I; Mendy M; Thursz M; Lemoine M
J Hepatol; 2018 Oct; 69(4):776-784. PubMed ID: 30104154
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HBV and HCV markers among patients attending the Saint Camille Medical Centre in Ouagadougou.
Zeba MT; Ouattara CA; Karou SD; Bisseye C; Ouermi D; Djigma FW; Sagna T; Pietra V; Moret R; Nikiema J; Simpore J
Pak J Biol Sci; 2012 May; 15(10):484-9. PubMed ID: 24187903
[TBL] [Abstract][Full Text] [Related]
11. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals.
Hyun CS; Ko O; Lee S; McMenamin J
BMC Infect Dis; 2019 Jul; 19(1):638. PubMed ID: 31319805
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis B virus infection and associated factors among healthcare workers in northern Tanzania.
Shao ER; Mboya IB; Gunda DW; Ruhangisa FG; Temu EM; Nkwama ML; Pyuza JJ; Kilonzo KG; Lyamuya FS; Maro VP
BMC Infect Dis; 2018 Sep; 18(1):474. PubMed ID: 30241503
[TBL] [Abstract][Full Text] [Related]
13. Increasing Hepatitis B Testing and Linkage to Care of Foreign-Born Asians, Sacramento, California, 2012-2013.
Dang JH; Chen MS
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):119-24. PubMed ID: 27168671
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
Spearman CW; Afihene M; Ally R; Apica B; Awuku Y; Cunha L; Dusheiko G; Gogela N; Kassianides C; Kew M; Lam P; Lesi O; Lohouès-Kouacou MJ; Mbaye PS; Musabeyezu E; Musau B; Ojo O; Rwegasha J; Scholz B; Shewaye AB; Tzeuton C; Sonderup MW;
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):900-909. PubMed ID: 29132759
[TBL] [Abstract][Full Text] [Related]
15. Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study.
Wongjarupong N; Oli S; Sanou M; Djigma F; Kiba Koumare A; Yonli AT; Hassan MA; Mara K; Harmsen WS; Therneau T; Barro O; Vodounhessi G; Sawadogo S; Chamcheu JC; Simpore J; Roberts LR; Nagalo BM
Am J Trop Med Hyg; 2021 Feb; 104(4):1577-1581. PubMed ID: 33617474
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
Lemoine M; Shimakawa Y; Njie R; Taal M; Ndow G; Chemin I; Ghosh S; Njai HF; Jeng A; Sow A; Toure-Kane C; Mboup S; Suso P; Tamba S; Jatta A; Sarr L; Kambi A; Stanger W; Nayagam S; Howell J; Mpabanzi L; Nyan O; Corrah T; Whittle H; Taylor-Robinson SD; D'Alessandro U; Mendy M; Thursz MR;
Lancet Glob Health; 2016 Aug; 4(8):e559-67. PubMed ID: 27443781
[TBL] [Abstract][Full Text] [Related]
17. HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso.
Compaore TR; Diarra B; Assih M; Obiri-Yeboah D; Soubeiga ST; Ouattara AK; Tchelougou D; Bisseye C; Bakouan DR; Compaore IP; Dembele A; Djigma WF; Simpore J
BMC Infect Dis; 2016 Jul; 16():336. PubMed ID: 27449138
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso.
Ouedraogo HG; Kouanda S; Grosso A; Compaoré R; Camara M; Dabire C; Ouedraogo R; Traore Y; Baral S; Barro N
Virol J; 2018 Dec; 15(1):194. PubMed ID: 30594218
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Hepatitis B virus and Hepatitis D virus Coinfection in Western Burkina Faso and molecular characterization of the detected virus strains.
Sanou AM; Benkirane K; Tinto B; Cissé A; Sagna T; Ilboudo AK; Dording C; Tarnagda Z; Muller CP; Hübschen JM
Int J Infect Dis; 2018 May; 70():15-19. PubMed ID: 29432880
[TBL] [Abstract][Full Text] [Related]
20. Performance of two simplified HBV treatment criteria (TREAT-B score and WHO guidelines) in Burkina Faso, West Africa.
Shimakawa Y; Boucheron P; Luong Nguyen LB; Lemoine M; Sombié R
J Hepatol; 2019 Oct; 71(4):842-844. PubMed ID: 31331666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
